Most importantly, a higher expression of TPSAB1 and C3 significantly correlated with poorer patient survival [log-rank (Mantel–Cox) p < 0.05] (Figure 8C), thus supporting the prognostic impact of C3+ MCs in melanoma. The gene discussed is C3; the disease is melanoma.